1.. Introduction {#s1}
================

Atrial fibrillation (AF), often co-existing with heart failure (HF) as a result of myocardial infarction (MI), is the most common sustained cardiac arrhythmia. It causes substantial morbidity and mortality, and is associated with electrical, structural, and contractile remodelling of the atrial myocardium.^[@CVT087C1],[@CVT087C2]^ Both re-entrant and non-re-entrant arrhythmias underlie AF initiation and maintenance, and which predominates depends on underlying cardiac pathophysiology and the pattern of associated atrial remodelling.^[@CVT087C3]^

Chronic ventricular tachypacing (VTP) models of HF-induced AF have been shown in numerous studies to cause atrial structural and electrophysiological remodelling, with a variety of changes in ion currents, action potentials (APs), and intracellular Ca^2+^(Ca^2+^~i~) handling. For example, AP duration (APD) is either increased,^[@CVT087C4],[@CVT087C5]^ unchanged,^[@CVT087C6]^ or shortened;^[@CVT087C7]^ the Ca^2+^~i~-transient amplitude is increased^[@CVT087C5]^ (in contrast with a decrease, in the ventricle),^[@CVT087C8]^ and delayed afterdepolarizations (DADs) also occur.^[@CVT087C4]^

However, there are few studies of effects of chronic ventricular MI-induced HF on atrial electrophysiology: in rats^[@CVT087C9]^ and dogs,^[@CVT087C10]^ MI promoted AF, and in dogs produced an alternating AP morphology, AP alternans.^[@CVT087C10]^ Moreover, there are no reports, to our knowledge, of effects of chronic MI on atrial Ca^2+^~i~ handling. Ventricular electrophysiological and Ca^2+^~i~-handling remodelling from chronic MI were studied in rabbits^[@CVT087C11],[@CVT087C12]^ and, although atrial enlargement occurred, no atrial electrophysiological or Ca^2+^-handling parameters were measured.

HF, in patients, is associated with increased adrenergic tone and elevated circulating levels of catecholamines.^[@CVT087C13]^ Catecholamines promote atrial arrhythmias, mainly by increasing L-type Ca^2+^ current (*I*~CaL~) and Ca^2+^~i~-transient amplitude.^[@CVT087C14]^ A reduced contractile response to β-adrenoceptor stimulation is well documented in failing ventricle, and *I*~CaL~ and Ca^2+^~i~-transient responses are also blunted,^[@CVT087C8]^ but corresponding atrial data are sparse. In the rat atrium, chronic MI reduced *I*~CaL~, and potentiated the *I*~CaL~ increase from β-stimulation.^[@CVT087C15]^ β-Stimulation may also affect APD alternans.^[@CVT087C16]^ APD alternans precede AF episodes in patients,^[@CVT087C17]^ and alternans are associated with Ca^2+^~i~-handling abnormalities.^[@CVT087C18]^ β-Stimulation enhances Ca^2+^~i~ cycling and excitation--contraction coupling, and either favours^[@CVT087C19]^ or protects against^[@CVT087C16],[@CVT087C20]^ alternans, depending on whether Ca^2+^ sequestration or fractional release of Ca^2+^ from the sarcoplasmic reticulum (SR) predominates.

Atrial conduction disturbances associated with structural changes, including fibrosis, chamber enlargement, and hypertrophy are well established, leading to increased vulnerability to AF.^[@CVT087C1],[@CVT087C21],[@CVT087C22]^ Decreased conduction velocity (CV) from fibrosis could promote re-entry by decreasing re-entry wavelength (*λ*), since *λ* = CV × ERP (effective refractory period). Altered atrial gap junction organization and connexin expression could also disturb intercellular connectivity, with the potential to decrease or increase CV.^[@CVT087C23]^ Furthermore, disruption of atrial transverse-tubules (t-tubules), as shown in a sheep VTP model of AF,^[@CVT087C24]^ may contribute to hypocontractility, Ca^2+^~i~-handling changes, and an increased propensity to arrhythmia in these diseased hearts. However, the effects of MI on atrial CV or the t-tubular network are also unknown.

We hypothesized that chronic MI would promote AF under β-stimulation, associated with any or all of the following: decreased atrial *λ*, increased APD alternans, increased DADs, altered Ca^2+^~i~ cycling, and disrupted t-tubules. Our aim, therefore, was two-fold: first, to characterize the atrial structural, electrophysiological, and Ca^2+^~i~-handling remodelling caused by chronic ventricular MI in rabbits; secondly, to investigate potential mechanisms of AF promotion by MI, by associating changes in propensity to AF with atrial APD, CV, APD alternans, DADs, *I*~CaL~, \[Ca^2+^\]~i~, and t-tubule density.

2.. Methods {#s2}
===========

2.1. Animal model of MI {#s2a}
-----------------------

Procedures conformed to the *Guide for the Care and Use of Laboratory Animals* published by US National Institutes of Health. Project license: 60/4206. Adult male New Zealand White rabbits (3.0--4.0 kg) were pre-medicated with intramuscular Hypnorm (0.3 mg/kg) and anaesthetized with midazolam (0.17--0.3 mg/kg) via the marginal ear vein. Ventilation was with N~2~O and O~2~ (1:1) containing 1% isofluorane. A thoracotomy was performed and the left descending coronary artery ligated to produce an ischaemic area of 30--40% of the left ventricle (LV) and subsequent apical infarction (*Figure [1](#CVT087F1){ref-type="fig"}Ai*). Post-surgery analgaesia: intramuscular Vetergesic (0.04 mg/kg). Sham-operated rabbits underwent thoracotomy without coronary artery ligation. LV function was assessed by echocardiography, under sedation with Hypnorm (0.3 mg/kg). Coronary artery-ligated animals with left ventricle ejection fraction (LVEF) \>45% were excluded from the MI group. Rabbits were humanely killed at the point of experimentation (8 weeks post-procedure) by sodium pentobarbitone (100 mg/kg) with 1000 IU heparin intravenously into the left marginal ear vein and removal of the heart. Figure 1LA cellular hypertrophy and t-tubule loss resulting from ventricular MI. (*A*) Rabbit model of MI (*i*), LVEF (*ii*), LV end-diastolic dimension (LVEDD) (*iii*) *n* = 13 non-MI hearts, 32 MI. (*B*) Cardiomyocyte capacitance (*i*); *n* = 52 cells (13 non-MI hearts) and 56 cells (15 MI), width (*ii*), and length (*iii*); *n* = 110 cells (6 non-MI hearts) and 191 (10 MI). (*C*) T-tubule (TT) density. Representative confocal images (*i*) LV non-MI cell (a), LA non-MI (b), LA MI (c); TT density (*ii*); *n* = 14 LV cells (six hearts), 18 LA cells (seven non-MI hearts), 30 LA cells (five MI). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.

2.2. Atrial cardiomyocyte isolation {#s2b}
-----------------------------------

Atrial cells were enzymatically dissociated as previously described.^[@CVT087C25]^ Briefly, the left atrium (LA) was dissected from the collagenase-digested heart, finely chopped, and gently shaken in enzyme, at 37°C. Tissues were re-suspended in enzyme and agitated, the supernatant centrifuged, and the cardiomyocyte pellet re-suspended in KB solution comprising (mM): KOH (70), KCl (40), [l]{.smallcaps}-glutamic acid (50), taurine (20), KH~2~PO~4~ (20), MgCl~2~ (3), glucose (10), HEPES (10), EGTA (0.5), pH 7.2 (37°C). This was repeated, twice. Cardiomyocyte length and width were measured using a crossed-scale eyepiece graticule (10 µm/division).

2.3. T-tubule density measurement {#s2c}
---------------------------------

T-tubule density quantification was based on a previous report.^[@CVT087C26]^ Briefly, cardiomyocytes were suspended in Krebs--Henseleit solution containing di-4-ANEPPS (10 µM) for 10 min. Confocal fluorescence Z-stack images were obtained with 1 µm inter-segment spacing, using an LSM510 laser-scanner. From a binary image of internal membranes, pixels with intensity ≥mean pixel value of the peripheral sarcolemma were attributed to t-tubule, and t-tubule density calculated relative to the total number of pixels occupied by the cell width in central segments, using custom-made software.

2.4. Intact heart atrial electrophysiological and optical recording {#s2d}
-------------------------------------------------------------------

Hearts were Langendorff perfused with Tyrode\'s solution comprising (mM): NaCl (120.9), KCl (5), MgSO~4~ (1), KH~2~PO~4~ (0.7), NaHCO~3~ (24.8), CaCl~2~ (1.8), glucose (15), 95% O~2~/5% CO~2~, with blebbistatin (mechanical uncoupler, 10 µM), with or without the β-adrenoceptor-agonist isoproterenol (ISO), 1 µM or the *I*~CaL~-blocker nifedipine (0.3 nM−3 µM), at 37°C, 35 mL/min. Drugs were protected from light during preparation and perfusion. Hearts were either unpaced, or paced (as specified) at 5 Hz with 2 ms pulses of twice diastolic threshold via bipolar electrodes hooked onto the right atrial appendage. Atrial vulnerability to AF induction was tested with a standard AF threshold (AFT) protocol: after 5 Hz pacing, short (1 s) bursts of high frequency (100 Hz) current pulses were delivered to the LA, increasing in 5 mA steps from 5 to 100 mA, until AF was induced. AFT was measured as the amplitude of the smallest current inducing AF lasting \>4 s, and a median value from five induction attempts calculated. For optical AP recording, hearts were loaded with di-4 ANEPPS (2 mM, 100 µL bolus), and APs measured from the LA epicardial surface using a 3 mm diameter light guide system. AP shape was assessed, including APD measurement at 50, 75, and 90% repolarization (APD~50,75,90~), and alternans magnitude was calculated as the mean of the absolute difference between consecutive APDs. LA CV was measured, in paced hearts, with a custom-made electrode comprising bipolar pacing electrodes and two electrogram-recording electrodes (1 mm apart), rotatable to allow CV measurement in the direction of fastest signal propagation, giving an estimate of atrial global CV. Data were acquired using custom-written programs (FL Burton), and analysed using those, MATLAB, or Origin 6.1.

2.5. Cellular electrophysiology and \[Ca^2+^\]~i~ {#s2e}
-------------------------------------------------

LA cardiomyocytes were superfused with a Krebs--Henseleit solution comprising (mM): NaCl (140), KCl (4), HEPES (5), MgCl~2~ (1), CaCl~2~ (1.8), glucose (11.1), pH 7.4 (37°C), with or without ISO or nifedipine. For recording cellular APs, microelectrodes (∼5--6 MΩ) contained (mM): KCl (20), K-aspartate (110), HEPES (5), MgCl~2~ (1), Na~2~ATP (4), disodium creatine phosphate (1), K~2~EGTA (0.15), pH 7.25. Cells were stimulated with 5 ms, 1 nA current pulses at 1 Hz for 90 s using an Axoclamp-2B amplifier and Clampex 9.2 software. In each cell, APs were recorded both with and without current clamping the resting membrane potential (RMP) (to −80 mV), since some cells in each group had an unclamped RMP more positive than ∼−60 mV and thus an inactivated *I*~Na~. APD~50--90~, and the occurrence of inter-AP spontaneous depolarizations (SDs), were monitored. For recording *I*~CaL~ and \[Ca^2+^\]~i~, microelectrodes contained (mM): KCl (20), K-aspartate (100), TEA-Cl (20), HEPES (10), MgCl~2~ (4.5), Na~2~ATP (4), Na~2~-creatine phosphate (1), K~2~EGTA (0.01), and Fura-2 (0.1 mM); pH 7.25, pCa ∼7.2. Extracellular 4-AP (5 mM), niflumic acid (0.1 mM) and TTX (5 µM) were used to eliminate contaminating currents. A voltage clamp protocol (*Figure [5](#CVT087F5){ref-type="fig"}Ai*) was cycled at 1 Hz for 90 s to record steady-state *I*~CaL~ and Ca^2+^~i~ transients. Fluorescence was measured at 340 and 380 nm every 15 ms using a Cairn Optoscan. Minimum (*R*~min~) and maximum (*R*~max~) fluorescence ratios (340/380 nm) were measured, and cytoplasmic \[Ca^2+^\] calculated as with *K*~d~ of 1.2 µM.^[@CVT087C27]^ The SR Ca^2+^ content was assessed by rapid application of 10 mM caffeine \[within ∼1 s of the end of the 90 s voltage-pulse train, using a 4 mm diameter perfusion pen (Cell Micro Controls, Norfolk, USA) in close proximity to the cell\] to fully release SR-Ca^2+^ stores, and estimated as the absolute time-integral of the resultant *I*~Na/Ca~, expressed in coulombs normalized to capacitance.^[@CVT087C27]^

2.6. Statistics {#s2f}
---------------

Continuous data are expressed as means ± SEM, and compared using unpaired or paired Student\'s *t*-tests, or ordinary or repeated measures ANOVA with appropriate post-tests. Categorical data were compared with a *χ*^2^ test. *P* \< 0.05 was considered statistically significant.

3.. Results {#s3}
===========

3.1. MI caused LV dysfunction, and LA cellular hypertrophy and detubulation {#s3a}
---------------------------------------------------------------------------

Ventricular MI decreased LVEF by 31% (*Figure [1](#CVT087F1){ref-type="fig"}Aii*) and increased LVEDD by 9% (*Figure [1](#CVT087F1){ref-type="fig"}Aiii*), with no significant effect on dimensions (mm) of LA (10.6 ± 0.2 in non-MI vs. 11.4 ± 0.3, MI), atrioventricular valve (3.1 ± 0.3 vs. 2.7 ± 0.1), or aorta (9.0 ± 0.3 vs. 8.6 ± 0.2). MI increased atrial cardiomyocyte capacitance by 56% (*Figure [1](#CVT087F1){ref-type="fig"}Bi*), width by 18% (*Figure [1](#CVT087F1){ref-type="fig"}Bii*), and length by 14% (*Figure [1](#CVT087F1){ref-type="fig"}Biii*). T-tubule density was lower in LA cells than LV cells (*Figure [1](#CVT087F1){ref-type="fig"}Ci*), and MI decreased LA t-tubule density by ∼60% (*Figure [1](#CVT087F1){ref-type="fig"}Cii*).

3.2. In the presence of β-stimulation, MI promoted AF, SDs, and APD alternans {#s3b}
-----------------------------------------------------------------------------

*Figure [2](#CVT087F2){ref-type="fig"}A* shows an original electrogram recording of AF induction in an intact non-MI heart. Under β-stimulation, AFT was decreased by MI, by 58% (*Figure [2](#CVT087F2){ref-type="fig"}Bi*), indicating increased susceptibility to AF, and AF duration was increased by 44% (*Figure [2](#CVT087F2){ref-type="fig"}Bii*). AF parameters were not altered by MI in the absence of β-stimulation. Atrial global CV was not altered by MI, with or without β-stimulation (*Figure [2](#CVT087F2){ref-type="fig"}Biii*). During AP-recording, in either paced or un-paced hearts, there was no evidence of atrial SDs in non-MI or MI, with or without β-stimulation. SDs occurred in isolated cardiomyocytes, categorized as threshold: premature APs with normal morphology; or subthreshold: low-amplitude diastolic depolarizations without regenerative phase 0. Under β-stimulation, MI markedly increased the number of threshold SDs (*Figure [2](#CVT087F2){ref-type="fig"}Cii*). Subthreshold SDs were infrequent (typically averaging \<1 per 30 s period of AP stimulation), in non-MI or MI, with or without β-stimulation, suggesting that MI+β-stimulation converted subthreshold SDs to threshold. *Figure [3](#CVT087F3){ref-type="fig"}A* shows an original recording of APD alternans, from an intact, paced, MI heart, in the absence of β-stimulation. In the unpaced hearts, the mean magnitude of APD alternans was not significantly affected by MI, either in the absence or presence of β-stimulation (*Figure [3](#CVT087F3){ref-type="fig"}B*). However, in the paced hearts, MI significantly increased APD alternans (*Figure [3](#CVT087F3){ref-type="fig"}C*), particularly, at APD~90~, by 147% in the presence of β-stimulation, and by 103% in its absence (*Figure [3](#CVT087F3){ref-type="fig"}Ciii*). Figure 2Under β-stimulation, atrial arrhythmia is provoked by MI. (*A*) Original electrogram recording of AF induction in a non-MI heart; pacing protocol shown beneath. (*B*) AFT (*i*) and AF duration (*ii*); *n* = 7 non-MI hearts, 7 MI. CV (*iii*); *n* = 6 non-MI, 5 MI. (*C*) SDs: original AP trace recorded in an MI atrial cell, showing SDs (\*) during stimulation (↑); bar = 250 ms (*i*); mean number (*ii*) and incidence (*iii*) of SDs occurring during AP trains. *n* = 23--31 cells, 12--13 hearts. ISO = 1 µM ISO. Figure 3Atrial APD alternans is increased by MI. (*A*) Original optical recording of an AP train (5 Hz pacing) from intact rabbit LA, post-ventricular MI, showing AP alternans. APD alternans magnitude in unpaced (*B*) and 5 Hz-paced (*C*) hearts, measured at 50% (*i*), 75% (*ii*), and 90% (*iii*) repolarization. *n* = 13 non-MI hearts, 12 MI.

3.3. Under β-stimulation, APD was not altered by MI {#s3c}
---------------------------------------------------

β-Stimulation increased intrinsic heart rate by 50--60% in non-MI and MI hearts (*Figure [4](#CVT087F4){ref-type="fig"}Ai*). In unpaced (*Figure [4](#CVT087F4){ref-type="fig"}A*) and paced (*Figure [4](#CVT087F4){ref-type="fig"}B*) hearts, under β-stimulation, MI had no significant effect on optically recorded atrial AP morphology or APD~50--90~. In contrast, in the absence of β-stimulation, MI increased APD~75~ and APD~90~, in unpaced (*Figure [4](#CVT087F4){ref-type="fig"}A*) and paced (*Figure [4](#CVT087F4){ref-type="fig"}*B) hearts. *Figure [4](#CVT087F4){ref-type="fig"}C* shows corresponding AP data obtained from isolated cardiomyocytes, comparable except for the lower stimulation rate (1 Hz), which perhaps accounts for the 'spikier' AP phase 1 (*Figure [4](#CVT087F4){ref-type="fig"}Ci*). Neither ISO nor MI affected RMP (*Figure [4](#CVT087F4){ref-type="fig"}Cii*) and, in agreement with the intact atrial AP data, MI had no significant effect on APD in the presence of β-stimulation (*Figure [4](#CVT087F4){ref-type="fig"}Ciii--v*), and tended to prolong APD in its absence. Figure 4Under β-stimulation, APD is not changed by MI. (*A*) Effects of MI and/or 1 µM ISO on rabbit isolated heart rate (*i*) and, in unpaced hearts, optically recorded atrial APs in non-MI (*ii*) and MI (*iii*), and on mean APD~50--90~ (*iv*--*vi*). (*B*) Corresponding data (*i*--*v*) obtained from paced (5 Hz) hearts. *n* = 13 non-MI, 12 MI. (*C*) Atrial isolated cardiomyocyte APs (*i*), at 1 Hz-stimulation, in non-MI (a) and MI (b). Effects of MI and/or ISO on RMP (*ii*) and, in cells with RMP clamped (−80 mV), APD~50--90~ (*iii--v*). *n* = 33 cells, 14 non-MI hearts, 22 cells, 11 MI.

3.4. Under β-stimulation, *I*~CaL~ and systolic \[Ca^2+^\]~i~ were decreased by MI {#s3d}
----------------------------------------------------------------------------------

*Figure [5](#CVT087F5){ref-type="fig"}* shows that in the presence of β-stimulation, but not in its absence, *I*~CaL~ density and Ca^2+^ flux through *I*~CaL~ (*Figure [5](#CVT087F5){ref-type="fig"}A* and *B*), and the systolic Ca^2+^~i~ transient (*Figure [5](#CVT087F5){ref-type="fig"}C* and *D*), were each significantly and similarly decreased by MI, while diastolic \[Ca^2+^\]~i~ was unaffected (*Figure [5](#CVT087F5){ref-type="fig"}Di*). Both the rate of decay of the Ca^2+^~i~ transient (*Figure [5](#CVT087F5){ref-type="fig"}Div*), and the SR Ca^2+^ content (*Figure [5](#CVT087F5){ref-type="fig"}Eii*), were increased by ISO, and not significantly affected by MI. Figure 5Under β-stimulation, *I*~CaL~ and systolic \[Ca^2+^\]~i~ are decreased by MI. Effects of MI and/or ISO on: (*A*) *I*~CaL~ stimulated with voltage-pulse (*i*) in non-MI (*ii*) and MI (*iii*) atrial cardiomyocytes. (*B*) *I*~CaL~ density (*i*) and Ca^2+^ flux via *I*~CaL~ (*ii*). (*C*) \[Ca^2+^\]~i~ recordings from non-MI (*i*) and MI (*ii*) cardiomyocytes. (*D*) Diastolic (*i*) and peak systolic (*ii*) \[Ca^2+^\]~i~, and Ca^2+^-transient amplitude (*iii*), and rate constant (RC) of decay (*iv*). *n* **=**13 non-MI hearts, 12 MI~.~ (*E*) Caffeine-evoked \[Ca^2+^\]~i~ increase (*i*) and resulting *I*~Na/Ca~ integral (*ii*), representing SR Ca^2+^ content. *n* = 7--10 non-MI hearts, 6--11 MI.

3.5. Pharmacological inhibition of *I*~CaL~, to mimic the *I*~CaL~ reduction from MI, did not promote AF {#s3e}
--------------------------------------------------------------------------------------------------------

In atrial cardiomyocytes from non-MI rabbits, nifedipine inhibited *I*~CaL~ in a concentration-dependent manner, with the inhibition significantly attenuated by ISO (*Figure [6](#CVT087F6){ref-type="fig"}Ai* and *ii*). Using the dose--response curve in the presence of ISO (*Figure [6](#CVT087F6){ref-type="fig"}Aii*, triangles), two concentrations of nifedipine were chosen, 0.02 and 2 µM (which inhibited *I*~CaL~ by 35 and 41%, respectively), to test effects of *I*~CaL~ reduction, in non-MI hearts and cells, on APDs and AFT under β-stimulation. Nifedipine at 0.02 and 2 µM shortened atrial cellular APD~90~, by 11 and 65%, respectively (*Figure [6](#CVT087F6){ref-type="fig"}Aiii*), and intact atrial epicardial APD~90~, by 30 and 42%, respectively (*Figure [6](#CVT087F6){ref-type="fig"}Bi*). The higher concentration (2 µM) markedly and significantly reduced the AFT, by 85% (*Figure [6](#CVT087F6){ref-type="fig"}Bii*). However, 0.02 µM nifedipine, which caused an equivalent *I*~CaL~ reduction to that produced by MI under β-stimulation (35%), did not affect AF susceptibility, despite significantly decreasing APD. Figure 6Under β-stimulation, *I*~CaL~ reduction to mimic that from MI, did not promote AF. (*A*) Effects of nifedipine (NIF) on isolated cardiomyocyte (non-MI): (*i*) *I*~CaL~, in the absence (a) and presence (b) of ISO; (*ii*) nifedipine concentration-dependence of *I*~CaL~ decrease, +/−ISO (*I*~max~ = maximum inhibitory effect; *n* = 3 hearts); (*iii*) APDs, under β-stimulation (*n* = 5 cells, 4 hearts). (*B*) Effects of *I*~CaL~ inhibition in intact, non-MI hearts under β-stimulation, on APDs (*i*) and AFT (*ii*). *n* = 13 hearts.

4.. Discussion {#s4}
==============

This is the first study, to our knowledge, to characterize the effects of chronic LV MI, rather than chronic VTP, on atrial Ca^2+^~i~ handling and electrophysiology. We recorded from intact atria, and isolated cardiomyocytes, with and without a β-agonist. The key findings are that under β-stimulation, MI promoted AF, APD alternans, and cellular SDs, associated with reduced *I*~CaL~, Ca^2+^~i~ transient and t-tubule density. β-Stimulation was used to represent *in-vivo* sympathetic activation (particularly in HF, with catecholamine elevation^[@CVT087C13]^), with consequent phosphorylation/activation of numerous ion channels and Ca^2+^~i~-handling proteins.^[@CVT087C14]^ We used ISO at supra-maximal concentration to ensure full adrenergic activation, but recognize that this is also supra-physiological.

The APD alternans could contribute to the increased AF susceptibility, by promoting spatial electrical heterogeneity and wavebreak.^[@CVT087C10]^ Since the SDs were not observed in intact atrium, this might suggest the alternans as the more likely contributor to the increased AF susceptibility. However, although isolated cardiomyocytes are more prone to afterdepolarizations than tissues, due to the absence of current sink, we cannot exclude the possibility that SDs occurred also in the intact hearts, remote from the myocardial region sensed by the fibre-optic detector. In support, chronic VTP-induced HF promoted DADs in atrial cells^[@CVT087C5]^ and triggered-activity characteristic or DADs in intact atria.^[@CVT087C4]^ Moreover, since MI increased APD alternans with or without ISO, yet MI increased AF susceptibility only with ISO, this argues against APD alternans as the sole potential electrophysiological mechanism, with the accompanying increase in SDs, as resulted from MI exclusively under β-stimulation, perhaps required.

MI affected neither atrial APD~90~ nor CV, under β-stimulation, and thus might not affect re-entry wavelength. However, although APD at late repolarization is a major determinant of ERP, the ERP has yet to be measured in this model. Furthermore, the MI is likely to increase atrial fibrosis, as in rats.^[@CVT087C9],[@CVT087C28]^ In rabbits, atrial fibrosis and inter-atrial conduction time were increased by VTP,^[@CVT087C29]^ and VTP-induced fibrosis in dogs was associated with spatial heterogeneity of CV, and local conduction abnormalities.^[@CVT087C21]^ Increased atrial myofibroblast density^[@CVT087C21]^ could promote AF via multiple arrhythmia mechanisms since, when coupled to cardiomyocytes, myofibroblasts can act as current sources and/or sinks, depending on myofibroblast density, distribution, and coupling strength, thereby modulating AP characteristics and CV, including production of SDs and alternans.^[@CVT087C30]^ Such fibrosis had a greater bearing on atrial CV disturbances and AF than gap junction remodelling (altered connexin subtype expression ratios, phosphorylation status, and cellular distribution), from chronic VTP.^[@CVT087C31]^ Nevertheless, whether atrial gap junctions are altered in the present model is unknown and the potential for such remodelling to disturb CV and cause arrhythmias, as proposed in failing ventricle,^[@CVT087C23]^ should not be excluded. We recorded CV at a fixed location, in the direction of fastest signal propagation, and acknowledge that extensive spatial, high-resolution analysis would be required to establish the contribution of local changes in CV and its heterogeneity to AF inducibility.

The present lack of effect of MI on atrial APD, under β-stimulation, contrasts with a canine model of chronic MI and sympathetic stimulation by tyramine, in which APD was decreased.^[@CVT087C32]^ We found that without β-stimulation, atrial APD was increased by MI. Previous studies of atrial electrophysiological remodelling by HF in rabbits used chronic VTP rather than MI, without β-stimulation, and showed increased APD,^[@CVT087C33]^ consistent with the present data, as well as increased ERP^[@CVT087C33]^ and altered K^+^ channel expression.^[@CVT087C34]^ The present APD increase is also consistent with several canine VTP studies, e.g.^[@CVT087C4]--[@CVT087C6]^ APD increase may enhance Ca^2+^~i~ transients as a result of AP plateau elevation from decreased *I*~TO~.^[@CVT087C35]^ Atrial APD decrease also occurs, after long-term (4 months) VTP in dogs,^[@CVT087C7]^ and with LV systolic dysfunction in patients.^[@CVT087C36]^ The ionic mechanism of the APD increase from chronic MI in rabbits is unknown, whereas in dogs, VTP decreased atrial *I*~TO~, *I*~CaL~, and *I*~Ks~, and increased *I*~Na/Ca~.^[@CVT087C1],[@CVT087C6]^ *I*~TO~ is prominent in the rabbit atrium, and since VTP decreased atrial Kv4.3,^[@CVT087C34]^ and *I*~TO~ decrease prolonged APD~90~ in rabbit atrial cells,^[@CVT087C37]^ *I*~TO~ reduction might contribute to the APD increase here. However, rabbit atrial *I*~TO~ is carried primarily by Kv1.4, not measured in the VTP study,^[@CVT087C34]^ which confers slow *I*~TO~ reactivation and could limit the contribution of *I*~TO~ to APD at physiological and supra-physiological rates.

Since MI provoked AF under β-stimulation, we measured *I*~CaL~ and the Ca^2+^~i~ transient under those conditions, and found both to be decreased. The reduced Ca^2+^~i~ transient likely resulted from the *I*~CaL~ reduction, since the SR Ca^2+^ content was unchanged. The mechanism of the *I*~CaL~ decrease is unclear, but may not involve altered *I*~CaL~ channel expression, since chronic MI in rats did not affect α~1C.~ ^[@CVT087C15]^ Another candidate is down-regulation of atrial β-adrenoceptors. We did not measure β-adrenoceptor density, but previous studies showed reduced atrial β~1~- and/or β~2~-expression in HF.^[@CVT087C38],[@CVT087C39]^ The potential contribution of this *I*~CaL~ reduction to the AF promotion was tested using nifedipine in intact hearts under β-stimulation. We took into account the effect of ISO to attenuate *I*~CaL~ block, as observed here and elsewhere.^[@CVT087C40]^ MI had decreased *I*~CaL~ by 35%, under β-stimulation. In non-MI hearts, nifedipine at 0.02 µM, which decreased *I*~CaL~ by an equivalent degree (35%), did not affect AF susceptibility, and moderately decreased APD. In contrast, maximally effective nifedipine (2 µM), which decreased atrial *I*~CaL~ by 41%, markedly decreased AFT, but that probably resulted from the accompanying marked decrease in APD; a change which did not result from the MI. Therefore, the whole-cell *I*~CaL~ reduction alone may not have contributed substantially to the MI-provoked AF. Indeed, *I*~CaL~ reduction, in the absence of the other atrial electrophysiological and structural consequences of chronic MI, could even suppress AF, since SDs may be provoked by increased *I*~CaL~ and Ca^2+^~i~ transient,^[@CVT087C14]^ and *I*~CaL~ inhibition, while inducing Ca^2+^~i~ alternans in rat ventricular cells,^[@CVT087C41]^ suppressed it in human atrial cells.^[@CVT087C42]^

However, both APD alternans and SDs result from a complex interaction between membrane potential, ion currents including *I*~CaL~ and *I*~Na/Ca~, and Ca^2+^~i~ cycling, each of which may be altered by myocardial disease as well as stimulation rate. Simultaneous measurement of \[Ca^2+^\]~i~ and APs in ventricular myocytes has suggested that APD alternans under rapid pacing is driven by Ca^2+^~i~ alternans.^[@CVT087C43]^ Ca^2+^~i~ alternans also occurred under tachypacing of cat atrial cells,^[@CVT087C16],[@CVT087C44]^ although APs were not measured. In rabbit atrial cells, Ca^2+^~i~ alternans induction depended on refractoriness of SR Ca^2+^ release.^[@CVT087C20]^ Studies of effects of myocardial disease on atrial alternans are sparse. In dogs, chronic MI,^[@CVT087C10]^ and chronic atrial tachypacing,^[@CVT087C45]^ promoted AF, which was preceded by increased atrial APD alternans. However, in neither report nor the present study was Ca^2+^~i~ alternans studied. Future studies of alternans in the present rabbit MI model of AF should attempt to measure \[Ca^2+^\]~i~ and APs simultaneously, in single cells and intact atrium, under supra-physiological and physiological stimulation rates.

We found that chronic MI caused atrial t-tubule loss, consistent with previous studies of atrial remodelling from chronic VTP^[@CVT087C24]^ and chronic AF.^[@CVT087C46],[@CVT087C47]^ The concurrent increase in cell capacitance, as with chronic MI in rats,^[@CVT087C15]^ infers cell size increase; confirmed here and in studies of chronic VTP^[@CVT087C24]^ or AF.^[@CVT087C46]^ It is unclear whether t-tubule loss contributes to the development of AF in HF, although t-tubule disorganization may promote atrial Ca^2+^~i~ alternans,^[@CVT087C18]^ with the potential to promote arrhythmia. The consequences of t-tubule loss for Ca^2+^~i~ cycling have been studied by de-tubulating rat ventricular myocytes using formamide, which decreased the Ca^2+^~i~ transient and slowed its decay, and de-synchronized SR Ca^2+^ release.^[@CVT087C48]^ MI did not affect the Ca^2+^~i~ transient or *I*~CaL~ in the absence of β-stimulation in the present, atrial, cells. No previous studies of rabbit atrial t-tubules and their reduction by myocardial disease could be found. T-tubules contain many of the elements of the β-adrenergic pathway, and the effects of de-tubulation in rat were prevented by β-stimulation, by re-synchronizing Ca^2+^ release.^[@CVT087C48]^ β-Stimulation inhibited atrial alternans,^[@CVT087C16],[@CVT087C20]^ by facilitating sequestration of Ca^2+^ from the cytosol.^[@CVT087C20]^ The present reduction in APD alternans by β-stimulation (in the paced hearts following MI) could involve a similar mechanism. Mathematical modelling suggests that t-tubule loss promotes Ca^2+^~i~ alternans by increasing intracellular spatial heterogeneity of Ca^2+^ diffusion, and steepening the relationship between SR \[Ca^2+^\] and cytoplasmic \[Ca^2+^\].^[@CVT087C49]^ Chronic MI caused frequent failure of AP propagation into subcellular regions which underwent t-tubule remodelling, producing local 'SDs'.^[@CVT087C50]^ Increased SR Ca^2+^ leak and spontaneous Ca^2+^~i~ waves also promote SDs.^[@CVT087C51],[@CVT087C52]^

In conclusion, chronic MI in rabbits remodels atrial structure, electrophysiology and Ca^2+^~i~ handling. Increased susceptibility to AF by MI, under β-stimulation, may result from associated production of atrial APD alternans and SDs, since steady-state APD and global CV were unchanged under these conditions, and may be unrelated to the associated reduction in whole-cell *I*~CaL~. Further studies in this model are warranted, to clarify potential contributions of local conduction changes, and cellular and subcellular mechanisms of alternans, to the increased susceptibility to AF.
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